Patient Care and General Interest
A man who received quintuple bypass surgery in Little Rock, Arkansas, USA, plans to cycle a 50-mile race only two months later.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease - PCI
September 21, 2018
September 19, 2018
This comphrensive review by Spadaccio and Benedetto try to address the unanswered question: to stent or not to stent?
The conclusions underline that the higher cerebrovascular risks associated with surgery are still overcome by long term outcome.
July 31, 2018
Head and colleagues used a patient-data pooled analysis of 11 randomized clinical trials to compare stroke rates between surgical and percutaneous coronary revascularization.
July 25, 2018
Interesting to read that percutaneous coronary intervention did not confer any survival benefit (nor protection from myocardial infarction) in an international randomized controlled trial of 888 patients when compared to medical therapy!
May 23, 2018
Over 1200 patients with stable coronary artery disease and at least one angiographically-significant stenosis were randomized to percutaneous coronary intervention (PCI) plus medical therapy or medical therapy alone for lesions with fractional flow reserve (FFR) <0.8. FFR-guided PCI was associated with a significantly reduced composite outcome (d
April 20, 2018
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or hybrid coronary revascularization (HCR). Notably, the patients undergoing HCR had a LIMA to LAD via a minimally invasive appr
April 4, 2018
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Leanne Harling moderates a discussion with David Taggart and Phillippe Kolh on the future of coronary revascularization.
March 28, 2018
Freemantle and colleagues discuss evidence evaluating myocardial revascularization strategies, focusing in particular on conclusions that can and cannot be drawn from subgroup analyses.
March 5, 2018
A few months after its publication, the ORBITA trial results do not seem to have filtered adequately to cardiac multidisciplinary teams worldwide.
February 23, 2018
In this patient level meta-analysis of 11 randomised trials, the authors compare PCI using stents with CABG. In total, almost 12,000 randomised patients were included.